Life Healthcare Group Holdings Limited (LTGHY)
ValueMarkers Composite Index
12% above intrinsic value ($0)
Life Healthcare Group Holdings Limited (LTGHY) — VMCI valuation read
Life Healthcare Group Holdings Limited sits at VMCI 62/100, with the Healthcare sector median at 50. That 12-point spread is the first thing to note on LTGHY: it tells the reader the composite is favorable before any single ratio is examined, and the mid-cap tier sets the comparison set.
Form 4 disclosures on LTGHY are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.
**Investor frame.** The Value read on LTGHY: LTGHY trades at 16.0x earnings, 11% below the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 16.0% sits 6.0pp above the Healthcare median (10.0%). The Risk read: net debt to EBITDA of -1.4x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.
LTGHY fell 0.5% over the trailing 7 days, with a -10.2% read on a 30-day basis.
Life Healthcare Group Holdings Limited, together with its subsidiaries, operates private hospitals in South Africa, Canada, the United Kingdom, rest of Europe, and Internationally. It operates through two segments, Hospitals and Complementary Services; and Healthcare Services. The company provides range of acute hospitals and complementary services; Life Esidimeni services, such as chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, and primary healthcare and substance abuse recovery programs; and life employee health solutions, including on-site occupational and primary healthcare services and employee wellness programs. It also offers services in the areas of diagnostics, mental health, acute rehabilitation, renal dialysis, oncology, cardiology, neurology, orthopedic, pediatric, dermatology, ophthalmology, gynecology, and obstetric. In addition, the company provides diagnostic imaging services; magnetic resonance imaging and computerized tomography scanners; develops, manufactures, and distributes radiopharmaceuticals for use in positron emission tomography-computerized tomography (PET-CT) diagnostics. The company was formerly known as Afrox Healthcare Limited and changed its name to Life Healthcare Group Holdings Limited in January 2005. Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.
- CSWYF - China Shineway Pharmaceutical Group Limited
- CSWYF - China Shineway Pharmaceutical Group Limited
- MERK.JK - PT Merck Tbk
- SPRINT.ST - Sprint Bioscience AB (publ)
- CANTA.ST - Cantargia AB (publ)
- 234080.KS - JW Lifescience Corporation
- BDTX - Black Diamond Therapeutics, Inc.
- BDTX - Black Diamond Therapeutics, Inc.